SCHEMBL3967653

SCHEMBL3967653

CC(C)(C)c1cc(N(CC(C)(C)S(=O)(=O)c2ccc(Cl)cc2)C(=O)C2(S(=O)(=O)c3ccc(C(F)(F)F)cc3)CCOCC2)[nH]n1

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MMP13 P45452 11/20 0.40
MMP2 P08253 10/20 0.40
MMP9 P14780 10/20 0.40
MMP3 P08254 7/20 0.40
MMP8 P22894 7/20 0.40
MMP14 P50281 6/20 0.40
MMP1 P03956 4/20 0.40
MMP7 P09237 1/20 0.36
CNR2 P34972 3/20 0.35
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
PKM P14618 1/20 0.33
CYP2C19 P33261 1/20 0.33
RORC P51449 1/20 0.33
MAPT P10636 1/20 0.32
ADAM17 P78536 1/20 0.32
CNR1 P21554 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3967650 0.76 CNR2 (0.50) MMP13MMP2MMP9MMP3MMP8
SCHEMBL1464356 0.65 MMP2 (0.65) MMP13MMP2MMP9MMP3MMP8
SCHEMBL1463607 0.64 ATM (0.55) MMP13MMP9MMP1CYP3A4CYP2C19
SCHEMBL1464751 0.64 MMP2 (0.57) MMP13MMP2MMP9MMP3MMP8
SCHEMBL1464315 0.63 MMP13 (0.59) MMP13MMP2MMP9MMP3MMP8
SCHEMBL1464643 0.63 MMP2 (0.57) MMP13MMP2MMP9MMP3MMP8
SCHEMBL1464255 0.63 CNR2 (0.60) MMP13MMP2MMP9MMP3MMP8
SCHEMBL3967702 0.62 MMP13 (0.51) MMP13MMP2MMP9MMP3MMP8
SCHEMBL3964990 0.62 MMP2 (0.48) MMP13MMP2MMP9MMP3MMP8
SCHEMBL3968969 0.61 ATM (0.41) MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2081905-A2 SULFONYL COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR Boehringer Ingelheim International GmbH (DE) 2009-07-29 EP claimed
WO-2008014199-A2 SULFONYL COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2008-01-31 WO claimed